The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1

A Ola1, R Kerkelä, H Tokola

  • 1Institute of Biomedicine, Department of Pharmacology and Toxicology, Biocenter Oulu, University of Oulu, Oulu, Finland.

Abstract

Insights

Mixed-lineage kinase (MLK) inhibition suppresses cardiac hypertrophy by blocking key transcription factors. This study shows MLK1-3 inhibition reduces stress responses and cardiac gene activation in heart cells.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Signal Transduction

Background:

  • Mixed-lineage kinases (MLKs) are upstream regulators of mitogen-activated protein kinases (MAPKs).
  • The specific role of MLKs in cardiac physiology and pathology remains largely uncharacterized.

Purpose of the Study:

  • To investigate the impact of a mixed-lineage kinase 1-3 (MLK1-3) inhibitor, CEP-11004, on G protein-coupled receptor agonist-induced stress responses in neonatal rat cardiac myocytes.
  • To elucidate the downstream signaling pathways affected by MLK inhibition in the context of cardiac stress.

Main Methods:

  • Primary neonatal rat cardiac myocytes were cultured and treated with G protein-coupled receptor agonists (phenylephrine and endothelin-1).
  • The effects of CEP-11004 on c-Jun N-terminal kinase (JNK) and p38 MAPK phosphorylation were assessed.
  • Activator protein-1 (AP-1) and GATA-binding protein 4 (GATA-4) binding activities, as well as B-type natriuretic peptide (BNP) gene transcription, were measured.
  • Secretion of atrial natriuretic peptide (ANP) and BNP was quantified.

Main Results:

  • CEP-11004 dose-dependently attenuated phenylephrine and endothelin-1 (ET-1)-induced c-Jun N-terminal kinase (JNK) activation.
  • MLK inhibition reduced ET-1- and phenylephrine-induced p38 MAPK phosphorylation.
  • CEP-11004 administration significantly decreased ET-1- and phenylephrine-induced activator protein-1 (AP-1) binding activity.
  • MLK inhibition attenuated ET-1-induced GATA-binding protein 4 (GATA-4) binding activity and phenylephrine-induced B-type natriuretic peptide (BNP) gene transcription.
  • Agonist-induced secretion of atrial natriuretic peptide (ANP) and BNP was reduced by MLK inhibition.

Conclusions:

  • Inhibition of the MLK1-3 signaling pathway effectively suppresses key nuclear effectors, including GATA-4 and AP-1 transcription factors, in models of cardiac hypertrophy.
  • MLK1-3 inhibition attenuates agonist-induced atrial natriuretic peptide secretion and B-type natriuretic peptide gene transcription.
  • Targeting the MLK1-3 pathway represents a potential therapeutic strategy for mitigating cardiac hypertrophy.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...